Evaluation of Canakinumab in High-Risk Former-Smokers
Part of paid clinical trials in Columbus, Ohio.
- Sponsor
- Peter Shields
- Study ID
- NCT06038526
- Phase
- PHASE2
- Status
- Active Not Recruiting
Conditions
- Cigarette Smoking-Related Carcinoma
- Lung Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - 73 Years
- Healthy Volunteers
- Accepted
Interventions
- Biospecimen Collection — PROCEDUREUndergo buccal, nasal, and blood sample collection
- Bronchoscopy — PROCEDUREUndergo bronchoscopy
- Canakinumab — BIOLOGICALGiven SC
- Carbon Monoxide Measurement — PROCEDUREUndergo CO testing
- Survey Administration — OTHERAncillary studies
Study Details
This phase II trial tests the impact of canakinumab on biologic samples (buccal, nasal, and blood) from former smokers with increased risk of cancer. Canakinumab blocks the activity of a protein called interleukin-1 beta (IL-1b), an agent of the inflammatory system and is used for the treatment of different non-cancer diseases (like auto-inflammatory diseases). Giving canakinumab may block the inflammatory system and could have positive effects to reduce cancer growth.
Key Dates
- Start date
- Mar 11, 2024
- Status verified
- May 2026
- Primary completion
- Jul 30, 2026
- Completion
- Jul 31, 2026
Study Design
- Enrollment
- 41 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- PREVENTION
Arms
- Experimental: Prevention (canakinumab, bronchoscopy)Patients undergo bronchoscopy over 30-60 minutes and receive canakinumab SC 60 minutes and 2 weeks after the initial bronchoscopy. Patients undergo an additional bronchoscopy on day 77. Patients undergo buccal, nasal, and blood sample collection and CO testing on study.
Primary Outcome Measure
Change in ASCs (apoptosis-associated speck-like protein containing a caspase activation and recruitment domain) [ Time Frame: At baseline and day 77 ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Ohio State University Comprehensive Cancer Center | Columbus | Ohio | 43210 | - |
Find similar trials in Columbus, OH
By condition
By specialty
By research site
Related Studies
- Reaching Rural Cancer Survivors Who Smoke Using Text-Based ProgramPHASE3 · Recruiting · Alliance for Clinical Trials in Oncology · Kingman, Arizona
- Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their CaregiversRecruiting · City of Hope Medical Center · Davis, California
- A Comprehensive Evaluation of Tobacco-Flavored vs. Non-Tobacco Flavored E-cigarettes on Smoking BehaviorRecruiting · Ohio State University Comprehensive Cancer Center · Columbus, Ohio
- Smoking Cessation Intervention Development for Homeless YouthRecruiting · Ohio State University Comprehensive Cancer Center · Columbus, Ohio